Clinical Trial Update: Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adding Herombopag to Cyclosporine in non-severe aplastic anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-severe Aplastic Anemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Herombopag (herombopag)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Non Severe Aplastic Anemia, Untreated | Phase 2 | Status: COMPLETED